Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Baxter
Daiichi Sankyo
Covington
Citi
Teva
Colorcon
Express Scripts
Moodys

Generated: January 17, 2018

DrugPatentWatch Database Preview

Caribe Holdings Company Profile

« Back to Dashboard

What is the competitive landscape for CARIBE HOLDINGS, and what generic and branded alternatives to CARIBE HOLDINGS drugs are available?

CARIBE HOLDINGS has two approved drugs.



Summary for Caribe Holdings
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Caribe Holdings

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Caribe Holdings DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062269-003 Approved Prior to Jan 1, 1982 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Caribe Holdings DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062269-002 Nov 8, 1982 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Caribe Holdings GEMFIBROZIL gemfibrozil TABLET;ORAL 078012-001 Mar 26, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Deloitte
Teva
Harvard Business School
Chinese Patent Office
Moodys
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot